Indian equity markets showed recovery with a rise in NSE Nifty 50, ending a four-session losing streak. Several companies reported their Se...

At least 46 companies are expected to report double-digit profit declines in Q2, despite Motilal Oswal projecting 22% earnings growth for i...

Revenue and net profit of Nifty 50 companies are projected to grow by nearly 20% year-on-year. Analysts note that performance is driven by ...

In a day of mixed economic signals, Indian markets displayed notable volatility before settling at a flat close. PB Fintech enjoyed a subst...

Indian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...

Cipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a...

Pharma major Cipla announced a significant 55% drop in its net profit for the March quarter. Total income also saw a 3% decrease. For the f...

Cipla's fourth-quarter net profit saw a significant drop of 55 percent year-on-year. For the full financial year, the company's profit also...

Cipla shares dropped 5% after reporting a 57% year-on-year decline in net profit to Rs 676 crore, impacted by a fall in gRevlimid sales. Re...

Analysts had expected Cipla to report a consolidated net profit of Rs 616.8 crore on net sales of Rs 5,003 crore, according to estimates fr...

Shares of Cipla fell 4.55 per cent in intraday trade on Monday, despite reporting an over two-fold jump in its consolidated net profit.

Pharmaceutical firm Cipla Ltd today reported 15.31 per cent increase in its consolidated net profit at Rs 327.85 crore in the third quarter...

Drug major Cipla today posted 25.51 per cent increase in profit after tax at Rs 338.78 crore for the third quarter ended December 31, 2012.

Cipla said its consolidated net profit rose by 61.83 per cent to Rs 500.01 crore for the second quarter ended Sept 30, 2012, due to robust ...

Cipla, India's second largest pharma company, has reported 36% increase in net profit in the quarter ended March.

Cipla Ltd reported a net profit of Rs 291.74 crore for the quarter ended March 31, 2012, compared to Rs 214 crore for the quarter ended Mar...

Drug major Cipla on Friday said its net profit declined by 1.58 per cent to Rs 253.34 crore for the quarter ended June 30, 2011, over the s...